Pakistan's growing presence at the Health Expo in Baghdad — tapping into a $500M+ pharma import market.
Baghdad, Iraq (International Fair Ground)
Iraq imports $500M+ in pharmaceuticals annually
Pakistan exports $17.14M to Iraq — strong growth trajectory
Hospital procurement, Ministry of Health tenders, private pharma chains
Iraq is Pakistan's 5th largest pharmaceutical export destination at $17.14M (FY 2024–25). Iraq's total pharmaceutical import bill exceeds $500 million annually, driven by a population of 42 million and significant government health spending. The market is predominantly generics-driven, with strong demand for antibiotics, cardiovascular drugs, and diabetes medications — all categories in which Pakistan has competitive strength.
TDAP organizes Pakistan's participation at the annual Health Expo in Baghdad, Iraq. The Pakistan Pavilion showcases pharmaceutical products from registered manufacturers and facilitates direct meetings with Iraqi importers, pharmacies, hospital procurement teams, and Ministry of Health officials. Iraq's pharmaceutical distribution is dominated by private trading companies importing directly from manufacturers.
Iraq's State Company for Marketing Drugs and Medical Appliances (KIMADIA) is the primary government importer. Private importers are also active in the market. Drug registration in Iraq requires a submission to the Iraq Ministry of Health (IMOH). WHO GMP or equivalent certification is required for registration. DRAP-issued CoPPs are generally accepted as part of the dossier.